J-cain cream 10.56%

J-Cain Cream 10.56% is a high-potency topical anesthetic formulated to deliver fast and effective pain relief during aesthetic and dermatological procedures. Powered by a strong concentration of lidocaine, it ensures a comfortable, pain-free experience for treatments like laser therapy, tattooing, microneedling, and filler injections. Its smooth consistency allows for easy application and deep skin penetration.

Formulation

• Active Ingredient: Lidocaine 10.56% – a potent amide-type local anesthetic that temporarily blocks nerve signals in the skin, reducing pain sensation.

• Inactive Components: Purified water, emulsifiers, stabilizers, and preservatives

• Form: Smooth, white to light yellow cream

• Texture: Semi-viscous and easy to spread evenly

• Origin: Manufactured under pharmaceutical-grade conditions in South Korea

Benefits

• Provides a deep anesthetic effect up to 8mm beneath the skin

• Begins working within 20–30 minutes of application

• Lasts 60–90 minutes for most aesthetic procedures

• Enhances client comfort and procedure precision

• Suitable for use by professionals across multiple treatment types

Scope of Application

• Laser hair removal and skin resurfacing

• Dermal filler and botulinum toxin injections

• Tattooing and permanent makeup

• Microneedling, mesotherapy, and microblading

• Minor cosmetic procedures and skin treatments

Indication

• For temporary topical anesthesia on intact skin prior to painful or minimally invasive procedures

• Not for use on mucous membranes, open wounds, or broken skin

• Designed for professional external use only

Duration of Effect

• Onset: Within 20–30 minutes under occlusion

• Duration: Typically 60–90 minutes

• Penetration Depth: Effective up to 8mm

Packaging and Specifications

• Net Content: 500g per container

• Packaging: Sealed plastic jar with secure twist-off lid

• Storage Conditions: Store at 1°C to 30°C in a dry, cool place away from sunlight

• Shelf Life: 24 months from manufacturing date

• Manufacturer: Inist BioPharma Co., Ltd., South Korea